GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSS) » Definitions » Cash per Share

STSS (Sharps Technology) Cash per Share : $1.46 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sharps Technology Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Sharps Technology's Cash per Share for the quarter that ended in Sep. 2024 was $1.46.

Sharps Technology Cash per Share Historical Data

The historical data trend for Sharps Technology's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sharps Technology Cash per Share Chart

Sharps Technology Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash per Share
4.29 4.17 9.75 4.34

Sharps Technology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 4.34 1.64 1.14 1.46

Sharps Technology Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Sharps Technology's Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=3.013/0.69
=4.34

Sharps Technology's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

Cash per Share= Cash, Cash Equivalents, Marketable Securities /Shares Outstanding (EOP)
=2.473/1.69
=1.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sharps Technology  (NAS:STSS) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Sharps Technology Cash per Share Related Terms

Thank you for viewing the detailed overview of Sharps Technology's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Sharps Technology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sharps Technology Inc (NAS:STSS) » Definitions » Cash per Share
Comparable Companies
RSCF IMTH SDCCQ LUCY ECIA AVGR NXGL GCTK POAI WHSI ISRG XPAR:EL BDX TSE:7741 XSWX:ALC WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
N/A
Address
105 Maxess Road, Suite 124, Melville, NY, USA, 11747
Website
https://www.sharpstechnology.com
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.
Executives
Robert Michael Hayes director, officer: Chief Executive Officer 75 BROOKSHIRE DRIVE, YOUNGSVILLE NC 27596
Andrew R. Crescenzo officer: Chief Financial Officer C/O ENZO BIOCHEM, 527 MADISON AVENUE, NEW YORK NY 10022
Timothy James Ruemler director 3311 RIVERPARK CT., BENITA SPRINGS FL 34134
Alan R. Blackman director, officer: CIO and COO 11502 ROBLES DR. REPP PLACE, TEMPLE TERRACE FL 33617
Paul K Danner director
Soren Bo Christiansen director 4059 SPRING VALLEY ROAD, DOYLESTOWN PA 18902
Brenda Baird Simpson director 7336 PRAIRIE STAR COURT,, PARKER CO 80134
Jason L. Monroe director 14527 LINDALE ROSE LANE, HUMBLE TX 77379
Barry Boris Berler officer: CTO and Inventor 77 HERZL STREET, RAMAT GAN L3 5244352